No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: For what it’s worth
Reply New Message
Back To Forum List View
For what it’s worth
6
jbuffett62
Jul 19, 2023 10:06AM
Re: For what it’s worth
3
KOO-KOO2
Jul 19, 2023 10:40AM
Re: For what it’s worth
2
tada
Jul 19, 2023 05:11PM
Re: For what it’s worth
2
tada
Jul 19, 2023 05:13PM

tada, but ZEN 3694 is not collaborating with another Big Pharma drug. That is what I meant to convey by the term stand-alone.

ZEN-3694 is kicking and screaming IPO on NASDAQ, right out of the gate !!!

 

Koo

3 Recommendations
Re: For what it’s worth
3
jbuffett62
Jul 20, 2023 08:04AM
Re: For what it’s worth
3
Buckeyes
Jul 20, 2023 08:18AM
Re: For what it’s worth
4
jbuffett62
Jul 20, 2023 08:35AM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply